Login / Signup
Islam Zaki
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 3
Top Topics
Intelligent Agents
Design Choices
Agent Oriented
X Ray
Top Venues
Symmetry
</>
Publications
</>
Tarfah Al-Warhi
,
Leena S. Alqahtani
,
Ghadi Alsharif
,
Matokah M. Abualnaja
,
Ola A. Abu Ali
,
Safa H. Qahl
,
Hussam Awwadh E. Althagafi
,
Fahad Alharthi
,
Ibrahim Jafri
,
Fahmy G. Elsaid
,
Ali A. Shati
,
Salman Aloufi
,
Eman Fayad
,
Islam Zaki
,
Martha M. Morcoss
Design, Synthesis, and Investigation of Cytotoxic Activity of cis-Vinylamide-Linked Combretastatin Analogues as Potential Anticancer Agents.
Symmetry
14 (10) (2022)
Tarfah Al-Warhi
,
Matokah M. Abualnaja
,
Ola A. Abu Ali
,
Najiah M. Alyamani
,
Fahmy G. Elsaid
,
Ali A. Shati
,
Sarah Albogami
,
Eman Fayad
,
Ali H. Abu Almaaty
,
Khaled O. Mohamed
,
Wael M. Alamoudi
,
Islam Zaki
Design, Synthesis and Cytotoxicity Screening of New Thiazole Derivatives as Potential Anticancer Agents through VEGFR-2 Inhibition.
Symmetry
14 (9) (2022)
Tarfah Al-Warhi
,
Leena S. Alqahtani
,
Matokah M. Abualnaja
,
Saba Beigh
,
Ola A. Abu Ali
,
Fahmy G. Elsaid
,
Ali A. Shati
,
Rasha Mohammed Saleem
,
Ali Hassan Ahmed Maghrabi
,
Amani Abdulrahman Alharthi
,
Amal Alyamani
,
Eman Fayad
,
Ali H. Abu Almaaty
,
Islam Zaki
,
Shaimaa Hamouda
Design, Synthesis, and In Vitro Antiproliferative Screening of New Hydrazone Derivatives Containing cis-(4-Chlorostyryl) Amide Moiety.
Symmetry
14 (11) (2022)